SmarterDividends
ORMP

Oramed Pharmaceuticals Inc.

ORMP

Healthcare · Stock · annual payer

$4.70

Overvalued · -25% Add to Portfolio

Forward Yield

5.29%

Annual Dividend

$0.25

Payout Ratio

6%

5-Yr Growth

Ex-Date

Jan 16, 2026

Frequency

Annual

Summary

As of September 2026, Oramed Pharmaceuticals Inc. (ORMP) yields 5.29% ($0.25 per share annually), with a blended fair-value estimate of $3.53 — -25% downside, so it screens as overvalued.

Is ORMP a good dividend stock?

Mixed

Oramed Pharmaceuticals Inc. (ORMP) pays a annual dividend yielding 5.29% ($0.25/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Never cut its dividend on record
  • Comfortable payout ratio (6%)

Risks

  • Share price is down over the past 5 years

Key Data

Dividend Yield
5.29%
Payout Ratio
6%
Annual Dividend
$0.25
5-Yr Avg Growth
Ex-Dividend Date
Jan 16, 2026
Years of Growth
0
Frequency
annual
Beta
1.19
Market Cap
$192.4M
P/E Ratio
1.1
5-Yr Total Return
-80%
52-Week Range
$2.09 – $5.47
Dividend Safety
Ever Cut?
No
ORMP ex-dividend date & scheduleNext ex-date Jan 16, 2026 · full ex-dividend historyView →

Frequently Asked Questions